𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease

✍ Scribed by Irune Cariñanos; Manuel Barreiro-De Acosta; Eugeni Domènech


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
50 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Adalimumab treatment for peristomal pyod
✍ Naim Alkhouri; Vera Hupertz; Lori Mahajan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 3 views

PG) is an uncommon neutrophilic dermatosis first described by Brunsting et al in 1930. 1 It is a painful, chronic ulcerating inflammatory skin condition that appears to be immune-mediated. The characteristic lesion begins as small erythematous papules that rapidly spread concentrically, coalesce, an

Liver diseases associated with anti-tumo
✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha

Disease phenotype and genotype are assoc
✍ Daniel N. Frank; Charles E. Robertson; Christina M. Hamm; Zegbeh Kpadeh; Tianyi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Background: Abnormal host-microbe interactions are implicated in the pathogenesis of inflammatory bowel diseases. Previous 16S rRNA sequence analysis of intestinal tissues demonstrated that a subset of Crohn's disease (CD) and ulcerative colitis (UC) samples exhibited altered intestinal-associated m

Cytokine association with bacterial DNA
✍ Ana Gutiérrez; Rubén Francés; Amparo Amorós; Pedro Zapater; Marta Garmendia; Moi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Background: The pathogenesis of inflammatory bowel disease (ibd) involves the interaction between genetic susceptibility, mucosal immunity, and intestinal bacteria. bacterial translocation is a common event in these patients and plays an important role in the perpetuation of chronic intestinal i